Skip to content
Methodology
All entries for: Vega Therapeutics Inc.
October 1, 2025
Vega Therapeutics Inc.
Orphan Drug Designation
FDA orphan drug designation: treatment of hemophilia B
Disease Area:
Rare Diseases
Source
Scroll to Top
